MedPath

Comparison og Triphala Gel and Chlorhehidine Gel as Local Drug Delivery Agent in Chronic Periodontitis Patients

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/03/017924
Lead Sponsor
Arpeet Krantikar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients in good systemic health

2.The patients ranged in age from 20 to 60 years

3.Patients with chronic periodontitis with isolated periodontal pockets. (probing pocket depths [PPDs] >=5 mm)

4.Patients with a minimum of 10 teeth in their total dentition

5.Cooperative patients who can be motivated to maintain good oral hygiene.

Exclusion Criteria

1.Subjects who did not give consent.

2.Subjects using antibiotic medications, mouthwashes, chewing gums, tobacco at the time of the study or 6months prior to it.

3.Patients with known hypersensitivity to Chlorhexidine.

4.Patients with furcation involvement;

5.Subjects having any oral or systemic disease.

6.Pregnant and/or lactating mothers.

7.Patients with any bleeding disorders or on anticoagulant therapy.

8.Patients who had received any type of periodontal therapy for the past 6 months

9.Patients who were smokers or had tobacco in any other form.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Plaque Index (P.I.)(TURSKEY-GILMORE-GLICKMAN MODIFICATION OF QUIGLEY HEIN). <br/ ><br>2.Gingival Index (G.I.) (LOE &SILNESS, 1963). <br/ ><br>3.Probing Pocket Depth (PPD). <br/ ><br>4.Clinical Attachment Level (CAL). <br/ ><br>Timepoint: Outcomes assesed at Baseline, 1 month after Scaling and Root Planing and 3 months after application of LDD
Secondary Outcome Measures
NameTimeMethod
Salivary Matrix Metalloproteinases-8 Levels by using ELISATimepoint: Outcome assessed at baseline, 1 month after Scaling and Root planing and 3 months after LDD placement
© Copyright 2025. All Rights Reserved by MedPath